Human DNA Vaccine Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Mode of Administration (Intramuscular, Subcutaneous, Intradermal, Others), By Application (Oncology, Tuberculosis, HIV, Human Papillomavirus, Others), By End User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others), By
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationHuman DNA Vaccine Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Mode of Administration (Intramuscular, Subcutaneous, Intradermal, Others), By Application (Oncology, Tuberculosis, HIV, Human Papillomavirus, Others), By End User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others), By
According to Global Cancer Observatory, in 2020, around 19,292,789 new cancer cases were reported worldwide. Breast Cancer, Lung Cancer, Colorectum Cancer, Prostate Cancer and Stomach Cancer were the most prevalent types of cancer cases reported in 2020.
In 2021, the research & development expenditure in the pharmaceutical industry across the globe was around USD238 billion.
Rise in Prevalence of Different Diseases
. According to World Health Organization, around 50,550,287 number of cancer prevalence are reported worldwide in the last five years
Increase in Number of Antibiotics Resistant Pathogens
According to World Health Organization, 32 antibiotics were identified in clinical development which addressed the top priority pathogens.
Growth in R&D for DNA Vaccine
According to Clinicaltrials.gov, 247 clinical trials are in different phases of development across the globe for Human DNA Vaccine
Recent Developments
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry Research Assistance Council in August 2021. This vaccine illustrated higher safety, efficacy, and immunogenicity. The vaccine is administered into the skin without an injection and has been found to be 67% protective against symptomatic COVID-19 in clinical trials. ZyCoV-D is a three-dose intradermal vaccine applied using The PharmaJet needle-free system, Tropis, which can significantly reduce any side effects and improved quality. Zydus Cadila has received approval for Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D.
Download Free Sample Report
Market Segmentation
Company Profiles
BOEHRINGER INGELHEIM GmbH (Merial), ELI-LILLY (Novartis Animal Health), Gene One Life Science, GEOVAX LABS, INC, Inovio Pharmaceuticals (VGX Animal Health), Genexine, Inc., VIATRIS INC. (Rottapharm Biotech), Takara Holdings (Takara Bio), ZOETIS INC. (Fort dodge Animal Health), Zydus Lifesciences Limited are some of the key players operating in the global Human DNA Vaccine market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | · Mode of Administration · Application · End User · Region · Company |
| Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
| Country scope | United States; Canada; Mexico; Germany; France; United Kingdom; Spain; Italy; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa; Turkey; Egypt |
| Key companies profiled | BOEHRINGER INGELHEIM GmbH (Merial), ELI-LILLY (Novartis Animal Health), Gene One Life Science, GEOVAX LABS, INC, Inovio Pharmaceuticals (VGX Animal Health), Genexine, Inc., VIATRIS INC. (Rottapharm Biotech), Takara Holdings (Takara Bio), ZOETIS INC. (Fort dodge Animal Health), Zydus Lifesciences Limited |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy